Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
J. J. Repa,1S.
D. Turley,2J.-M. A. Lobaccaro,1*J. Medina,3L. Li,3K. Lustig,3B. Shan,3R. A. Heyman,4 J. M. Dietschy,2D. J. Mangelsdorf1
Several nuclear hormone receptors involved in lipid
metabolism form obligate heterodimers with retinoid X receptors (RXRs)and are activated by RXR agonists such as rexinoids. Animals treatedwith rexinoids exhibited marked changes in cholesterol balance,including inhibition of cholesterol absorption and repressed bileacid
synthesis. Studies with receptor-selective agonists revealedthat
oxysterol receptors (LXRs) and the bile acid receptor (FXR)are the RXR
heterodimeric partners that mediate these effectsby regulating
expression of the reverse cholesterol transporter,ABC1, and the
rate-limiting enzyme of bile acid synthesis, CYP7A1,respectively.
Thus, these RXR heterodimers serve as key regulatorsof cholesterol
homeostasis by governing reverse cholesterol transportfrom peripheral
tissues, bile acid synthesis in liver, and cholesterolabsorption in
intestine.
1 Howard Hughes Medical Institute and
Department of Pharmacology,
2 Department of Internal
Medicine, University of Texas Southwestern Medical Center, 5323 Harry
Hines Boulevard, Dallas, TX 75390-9050, USA.
3 Tularik, Two Corporate Drive, South San Francisco,
CA 94080, USA.
4 Ligand Pharmaceuticals, 10255 Science Center Drive, San Diego, CA 92121, USA.
*
Present address: Physiologie Comparée-Endocrinologie
Moléculaire, UMR CNRS 6547-GEEM, Université Blaise Pascal,
63177 AubièreCedex, France.
To whom correspondence should be addressed. E-mail:
davo.mango{at}utsouthwestern.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
NEWS OF THE WEEK
Dan Ferber (1 September 2000) Science289 (5484), 1446.
[DOI: 10.1126/science.289.5484.1446] |Summary »|Full Text »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Phenotypic Polarization of Macrophages in Atherosclerosis.
N. Leitinger and I. G. Schulman (2013)
Arterioscler Thromb Vasc Biol
33, 1120-1126
|Abstract »|Full Text »|PDF »
Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters.
C. Gardes, E. Chaput, A. Staempfli, D. Blum, H. Richter, and G. M. Benson (2013)
J. Lipid Res.
54, 1283-1299
|Abstract »|Full Text »|PDF »
Carboxylesterases Are Uniquely Expressed among Tissues and Regulated by Nuclear Hormone Receptors in the Mouse.
R. D. Jones, A. M. Taylor, E. Y. Tong, and J. J. Repa (2013)
Drug Metab. Dispos.
41, 40-49
|Abstract »|Full Text »|PDF »
Acute Psychological Stress Accelerates Reverse Cholesterol Transport via Corticosterone-Dependent Inhibition of Intestinal Cholesterol Absorption.
R. Silvennoinen, J. C. Escola-Gil, J. Julve, N. Rotllan, G. Llaverias, J. Metso, A. F. Valledor, J. He, L. Yu, M. Jauhiainen, et al. (2012)
Circ. Res.
111, 1459-1469
|Abstract »|Full Text »|PDF »
High Density Lipoprotein Biogenesis, Cholesterol Efflux, and Immune Cell Function.
M. G. Sorci-Thomas and M. J. Thomas (2012)
Arterioscler Thromb Vasc Biol
32, 2561-2565
|Abstract »|Full Text »|PDF »
Feedback Regulation of Cholesterol Uptake by the LXR-IDOL-LDLR Axis.
L. Zhang, K. Reue, L. G. Fong, S. G. Young, and P. Tontonoz (2012)
Arterioscler Thromb Vasc Biol
32, 2541-2546
|Abstract »|Full Text »|PDF »
Liver X Receptor Activation Reduces Angiogenesis by Impairing Lipid Raft Localization and Signaling of Vascular Endothelial Growth Factor Receptor-2.
A. Noghero, A. Perino, G. Seano, E. Saglio, G. L. Sasso, F. Veglio, L. Primo, E. Hirsch, F. Bussolino, and F. Morello (2012)
Arterioscler Thromb Vasc Biol
32, 2280-2288
|Abstract »|Full Text »|PDF »
Inactivation of AMPK{alpha}1 Induces Asthenozoospermia and Alters Spermatozoa Morphology.
P. Tartarin, E. Guibert, A. Toure, C. Ouiste, J. Leclerc, N. Sanz, S. Briere, J.-L. Dacheux, B. Delaleu, J. R. McNeilly, et al. (2012)
Endocrinology
153, 3468-3481
|Abstract »|Full Text »|PDF »
LXR Agonists and ABCG1-dependent Cholesterol Efflux in MCF-7 Breast Cancer Cells: Relation to Proliferation and Apoptosis.
A. EL ROZ, J.-M. BARD, J.-M. HUVELIN, and H. NAZIH (2012)
Anticancer Res
32, 3007-3013
|Abstract »|Full Text »|PDF »
Liver X Receptor Agonist Modulation of Cholesterol Efflux in Mice With Intestine-Specific Deletion of Microsomal Triglyceride Transfer Protein.
Y. Xie, S. Kennedy, R. Sidhu, J. Luo, D. S. Ory, and N. O. Davidson (2012)
Arterioscler Thromb Vasc Biol
32, 1624-1631
|Abstract »|Full Text »|PDF »
Differential Expression and Function of Alternative Splicing Variants of Human Liver X Receptor {alpha}.
K. Endo-Umeda, S. Uno, K. Fujimori, Y. Naito, K. Saito, K. Yamagishi, Y. Jeong, H. Miyachi, H. Tokiwa, S. Yamada, et al. (2012)
Mol. Pharmacol.
81, 800-810
|Abstract »|Full Text »|PDF »
Phytosterols Reduce Cholesterol Absorption by Inhibition of 27-Hydroxycholesterol Generation, Liver X Receptor {alpha} Activation, and Expression of the Basolateral Sterol Exporter ATP-Binding Cassette A1 in Caco-2 Enterocytes.
R. Brauner, C. Johannes, F. Ploessl, F. Bracher, and R. L. Lorenz (2012)
J. Nutr.
142, 981-989
|Abstract »|Full Text »|PDF »
Nuclear Hormone Receptors Enable Macrophages and Dendritic Cells to Sense Their Lipid Environment and Shape Their Immune Response.
L. Nagy, A. Szanto, I. Szatmari, and L. Szeles (2012)
Physiol Rev
92, 739-789
|Abstract »|Full Text »|PDF »
Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule.
S. Kittayaruksakul, S. Soodvilai, N. Asavapanumas, C. Muanprasat, and V. Chatsudthipong (2012)
Am J Physiol Renal Physiol
302, F552-F560
|Abstract »|Full Text »|PDF »
Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and Peroxisome Proliferator-Activated Receptor {alpha} in Mouse Liver Reveals Extensive Sharing of Binding Sites.
M. Boergesen, T. A. Pedersen, B. Gross, S. J. van Heeringen, D. Hagenbeek, C. Bindesboll, S. Caron, F. Lalloyer, K. R. Steffensen, H. I. Nebb, et al. (2012)
Mol. Cell. Biol.
32, 852-867
|Abstract »|Full Text »|PDF »
Retinoic Acid Isomers Up-Regulate ATP Binding Cassette A1 and G1 and Cholesterol Efflux in Rat Astrocytes: Implications for Their Therapeutic and Teratogenic Effects.
J. Chen, L. G. Costa, and M. Guizzetti (2011)
J. Pharmacol. Exp. Ther.
338, 870-878
|Abstract »|Full Text »|PDF »
Liver X Receptor {beta} (LXR{beta}) Interacts Directly with ATP-binding Cassette A1 (ABCA1) to Promote High Density Lipoprotein Formation during Acute Cholesterol Accumulation.
M. Hozoji-Inada, Y. Munehira, K. Nagao, N. Kioka, and K. Ueda (2011)
J. Biol. Chem.
286, 20117-20124
|Abstract »|Full Text »|PDF »
Targeted Disruption of the Idol Gene Alters Cellular Regulation of the Low-Density Lipoprotein Receptor by Sterols and Liver X Receptor Agonists.
E. Scotti, C. Hong, Y. Yoshinaga, Y. Tu, Y. Hu, N. Zelcer, R. Boyadjian, P. J. de Jong, S. G. Young, L. G. Fong, et al. (2011)
Mol. Cell. Biol.
31, 1885-1893
|Abstract »|Full Text »|PDF »
Liver X Receptors Inhibit Macrophage Proliferation through Downregulation of Cyclins D1 and B1 and Cyclin-Dependent Kinases 2 and 4.
M. Pascual-Garcia, J. M. Carbo, T. Leon, J. Matalonga, R. Out, T. Van Berkel, M.-R. Sarrias, F. Lozano, A. Celada, and A. F. Valledor (2011)
J. Immunol.
186, 4656-4667
|Abstract »|Full Text »|PDF »
Rumen epithelial adaptation to high-grain diets involves the coordinated regulation of genes involved in cholesterol homeostasis.
M. A. Steele, G. Vandervoort, O. AlZahal, S. E. Hook, J. C. Matthews, and B. W. McBride (2011)
Physiol Genomics
43, 308-316
|Abstract »|Full Text »|PDF »
Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome.
M. K. Basantani, M. T. Sitnick, L. Cai, D. S. Brenner, N. P. Gardner, J. Z. Li, G. Schoiswohl, K. Yang, M. Kumari, R. W. Gross, et al. (2011)
J. Lipid Res.
52, 318-329
|Abstract »|Full Text »|PDF »
Transcriptional and Posttranscriptional Control of Cholesterol Homeostasis by Liver X Receptors.
Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation.
I. Gerin, L.-A. Clerbaux, O. Haumont, N. Lanthier, A. K. Das, C. F. Burant, I. A. Leclercq, O. A. MacDougald, and G. T. Bommer (2010)
J. Biol. Chem.
285, 33652-33661
|Abstract »|Full Text »|PDF »
Group X Secretory Phospholipase A2 Negatively Regulates ABCA1 and ABCG1 Expression and Cholesterol Efflux in Macrophages.
P. Shridas, W. M. Bailey, F. Gizard, R. C. Oslund, M. H. Gelb, D. Bruemmer, and N. R. Webb (2010)
Arterioscler Thromb Vasc Biol
30, 2014-2021
|Abstract »|Full Text »|PDF »
Reduced VLDL clearance in Apoe-/-Npc1-/- mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.
M. Ishibashi, D. Masson, M. Westerterp, N. Wang, S. Sayers, R. Li, C. L. Welch, and A. R. Tall (2010)
J. Lipid Res.
51, 2655-2663
|Abstract »|Full Text »|PDF »
ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.
P. A. Thompson, K. C. Gauthier, A. W. Varley, and R. L. Kitchens (2010)
J. Lipid Res.
51, 2672-2685
|Abstract »|Full Text »|PDF »
Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms.
S.-Y. Cai, H. He, T. Nguyen, A. Mennone, and J. L. Boyer (2010)
J. Lipid Res.
51, 2265-2274
|Abstract »|Full Text »|PDF »
TNF-{alpha} decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2.
Activation of Liver X Receptor Sensitizes Human Dendritic Cells to Inflammatory Stimuli.
D. Torocsik, M. Barath, S. Benko, L. Szeles, B. Dezso, S. Poliska, Z. Hegyi, L. Homolya, I. Szatmari, A. Lanyi, et al. (2010)
J. Immunol.
184, 5456-5465
|Abstract »|Full Text »|PDF »
Non-redundant roles for LXR{alpha} and LXR{beta} in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.
E. D. Bischoff, C. L. Daige, M. Petrowski, H. Dedman, J. Pattison, J. Juliano, A. C. Li, and I. G. Schulman (2010)
J. Lipid Res.
51, 900-906
|Abstract »|Full Text »|PDF »
ABCA1 Gene Variants Regulate Postprandial Lipid Metabolism in Healthy Men.
J. Delgado-Lista, P. Perez-Martinez, F. Perez-Jimenez, A. Garcia-Rios, F. Fuentes, C. Marin, P. Gomez-Luna, A. Camargo, L. D. Parnell, J. M. Ordovas, et al. (2010)
Arterioscler Thromb Vasc Biol
30, 1051-1057
|Abstract »|Full Text »|PDF »
Intestinal and Hepatic Cholesterol Carriers in Diabetic Psammomys obesus.
E. Levy, G. Lalonde, E. Delvin, M. Elchebly, L. P. Precourt, N. G. Seidah, S. Spahis, R. Rabasa-Lhoret, and E. Ziv (2010)
Endocrinology
151, 958-970
|Abstract »|Full Text »|PDF »
Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
C. Crisafulli, R. Di Paola, E. Mazzon, I. Paterniti, M. Galuppo, T. Genovese, P. Bramanti, A. Cappellani, and S. Cuzzocrea (2010)
J. Leukoc. Biol.
87, 309-321
|Abstract »|Full Text »|PDF »
An Innate Immunity Signaling Process Suppresses Macrophage ABCA1 Expression through IRAK-1-Mediated Downregulation of Retinoic Acid Receptor {alpha} and NFATc2.
Elevated Insulin Secretion from Liver X Receptor-Activated Pancreatic {beta}-Cells Involves Increased de Novo Lipid Synthesis and Triacylglyceride Turnover.
C. D. Green, D. B. Jump, and L. K. Olson (2009)
Endocrinology
150, 2637-2645
|Abstract »|Full Text »|PDF »
Intestinal lipid absorption.
J. Iqbal and M. M. Hussain (2009)
Am J Physiol Endocrinol Metab
296, E1183-E1194
|Abstract »|Full Text »|PDF »
Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR-623, a Novel Liver X-Receptor Agonist, in Healthy Participants.
A. Katz, C. Udata, E. Ott, L. Hickey, M. E. Burczynski, P. Burghart, O. Vesterqvist, and X. Meng (2009)
J. Clin. Pharmacol.
49, 643-649
|Abstract »|Full Text »|PDF »
Nuclear Hormone Receptor Regulation of MicroRNAs Controls Developmental Progression.
A. Bethke, N. Fielenbach, Z. Wang, D. J. Mangelsdorf, and A. Antebi (2009)
Science
324, 95-98
|Abstract »|Full Text »|PDF »
A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
M. J. Evans, P. E. Mahaney, L. Borges-Marcucci, K. Lai, S. Wang, J. A. Krueger, S. J. Gardell, C. Huard, R. Martinez, G. P. Vlasuk, et al. (2009)
Am J Physiol Gastrointest Liver Physiol
296, G543-G552
|Abstract »|Full Text »|PDF »
Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8.
W. Tang, Y. Ma, L. Jia, Y. A. Ioannou, J. P. Davies, and L. Yu (2009)
J. Lipid Res.
50, 293-300
|Abstract »|Full Text »|PDF »
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia.
A. Kratzer, M. Buchebner, T. Pfeifer, T. M. Becker, G. Uray, M. Miyazaki, S. Miyazaki-Anzai, B. Ebner, P. G. Chandak, R. S. Kadam, et al. (2009)
J. Lipid Res.
50, 312-326
|Abstract »|Full Text »|PDF »
Minireview: Liver X Receptor {beta}: Emerging Roles in Physiology and Diseases.
C. Gabbi, M. Warner, and J.-A. Gustafsson (2009)
Mol. Endocrinol.
23, 129-136
|Abstract »|Full Text »|PDF »
Improved lipid profile through liver-specific knockdown of liver X receptor {alpha} in KKAy diabetic mice.
J. F. Rippmann, C. Schoelch, T. Nolte, H. Pavliska, A. van Marle, H. van Es, and J. Prestle (2009)
J. Lipid Res.
50, 22-31
|Abstract »|Full Text »|PDF »
Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle.
T. Kida, T. Murata, M. Hori, and H. Ozaki (2009)
Am J Physiol Heart Circ Physiol
296, H195-H201
|Abstract »|Full Text »|PDF »
Origins of intestinal ABCA1-mediated HDL-cholesterol.
Novel Peroxisome Proliferator-Activated Receptor {alpha} Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor Agonist.
R. Mukherjee, K. T. Locke, B. Miao, D. Meyers, H. Monshizadegan, R. Zhang, D. Search, D. Grimm, M. Flynn, K. M. O'Malley, et al. (2008)
J. Pharmacol. Exp. Ther.
327, 716-726
|Abstract »|Full Text »|PDF »
Antiatherosclerotic Effects of a Novel Synthetic Tissue-Selective Steroidal Liver X Receptor Agonist in Low-Density Lipoprotein Receptor-Deficient Mice.
D. Peng, R. A. Hiipakka, Q. Dai, J. Guo, C. A. Reardon, G. S. Getz, and S. Liao (2008)
J. Pharmacol. Exp. Ther.
327, 332-342
|Abstract »|Full Text »|PDF »
Direct Interaction of Nuclear Liver X Receptor-{beta} with ABCA1 Modulates Cholesterol Efflux.
M. Hozoji, Y. Munehira, Y. Ikeda, M. Makishima, M. Matsuo, N. Kioka, and K. Ueda (2008)
J. Biol. Chem.
283, 30057-30063
|Abstract »|Full Text »|PDF »
Insulation of the Ubiquitous Rxrb Promoter from the Cartilage-specific Adjacent Gene, Col11a2.
J. Murai, D. Ikegami, M. Okamoto, H. Yoshikawa, and N. Tsumaki (2008)
J. Biol. Chem.
283, 27677-27687
|Abstract »|Full Text »|PDF »
The Emerging Role of Nuclear Receptor ROR{alpha} and Its Crosstalk with LXR in Xeno- and Endobiotic Gene Regulation.
T. Wada, H. S. Kang, A. M. Jetten, and W. Xie (2008)
Exp Biol Med
233, 1191-1201
|Abstract »|Full Text »|PDF »
Selective Partial Agonism of Liver X Receptor {alpha} Is Related to Differential Corepressor Recruitment.
C. A. Phelan, J. M. Weaver, D. J. Steger, S. Joshi, J. T. Maslany, J. L. Collins, W. J. Zuercher, T. M. Willson, M. Walker, M. Jaye, et al. (2008)
Mol. Endocrinol.
22, 2241-2249
|Abstract »|Full Text »|PDF »
Intestine-Specific Regulation of PPAR{alpha} Gene Transcription by Liver X Receptors.
S. Colin, E. Bourguignon, A.-B. Boullay, J.-J. Tousaint, S. Huet, F. Caira, B. Staels, S. Lestavel, J.-M. A. Lobaccaro, and P. Delerive (2008)
Endocrinology
149, 5128-5135
|Abstract »|Full Text »|PDF »
A 9-cis {beta}-Carotene-Enriched Diet Inhibits Atherogenesis and Fatty Liver Formation in LDL Receptor Knockout Mice.
A. Harari, D. Harats, D. Marko, H. Cohen, I. Barshack, Y. Kamari, A. Gonen, Y. Gerber, A. Ben-Amotz, and A. Shaish (2008)
J. Nutr.
138, 1923-1930
|Abstract »|Full Text »|PDF »
Liver X Receptor Agonists Increase Airway Reactivity in a Model of Asthma via Increasing Airway Smooth Muscle Growth.
M. A. Birrell, J. De Alba, M. C. Catley, E. Hardaker, S. Wong, M. Collins, D. L. Clarke, S. N. Farrow, T. M. Willson, J. L. Collins, et al. (2008)
J. Immunol.
181, 4265-4271
|Abstract »|Full Text »|PDF »
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.
L. Calpe-Berdiel, N. Rotllan, C. Fievet, R. Roig, F. Blanco-Vaca, and J. C. Escola-Gil (2008)
J. Lipid Res.
49, 1904-1911
|Abstract »|Full Text »|PDF »
Increased Cellular Free Cholesterol in Macrophage-specific Abca1 Knock-out Mice Enhances Pro-inflammatory Response of Macrophages.
X. Zhu, J.-Y. Lee, J. M. Timmins, J. M. Brown, E. Boudyguina, A. Mulya, A. K. Gebre, M. C. Willingham, E. M. Hiltbold, N. Mishra, et al. (2008)
J. Biol. Chem.
283, 22930-22941
|Abstract »|Full Text »|PDF »
Identification of Upregulators of Human ATP-Binding Cassette Transporter A1 via High-Throughput Screening of a Synthetic and Natural Compound Library.
J. Gao, Y. Xu, Y. Yang, Y. Yang, Z. Zheng, W. Jiang, B. Hong, X. Yan, and S. Si (2008)
J Biomol Screen
13, 648-656
|Abstract »|PDF »
Regulation of Macrophage Functions by PPAR-{alpha}, PPAR-{gamma}, and LXRs in Mice and Men.
E. Rigamonti, G. Chinetti-Gbaguidi, and B. Staels (2008)
Arterioscler Thromb Vasc Biol
28, 1050-1059
|Abstract »|Full Text »|PDF »
Endoglin (CD105) Expression Is Regulated by the Liver X Receptor Alpha (NR1H3) in Human Trophoblast Cell Line JAR.
J. Henry-Berger, K. Mouzat, S. Baron, C. Bernabeu, G. Marceau, J.-P. Saru, V. Sapin, J.-M. A. Lobaccaro, and F. Caira (2008)
Biol Reprod
78, 968-975
|Abstract »|Full Text »|PDF »
The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
I. Zanotti, F. Poti, M. Pedrelli, E. Favari, E. Moleri, G. Franceschini, L. Calabresi, and F. Bernini (2008)
J. Lipid Res.
49, 954-960
|Abstract »|Full Text »|PDF »
Intestinal fatty acid binding protein regulates mitochondrion {beta}-oxidation and cholesterol uptake.
A. Montoudis, E. Seidman, F. Boudreau, J.-F. Beaulieu, D. Menard, M. Elchebly, G. Mailhot, A.-T. Sane, M. Lambert, E. Delvin, et al. (2008)
J. Lipid Res.
49, 961-972
|Abstract »|Full Text »|PDF »
Genetic variations and treatments that affect the lifespan of the NPC1 mouse.
B. Liu, H. Li, J. J. Repa, S. D. Turley, and J. M. Dietschy (2008)
J. Lipid Res.
49, 663-669
|Abstract »|Full Text »|PDF »
Effects of Liver X Receptor Agonist Treatment on Pulmonary Inflammation and Host Defense.
K. Smoak, J. Madenspacher, S. Jeyaseelan, B. Williams, D. Dixon, K. R. Poch, J. A. Nick, G. S. Worthen, and M. B. Fessler (2008)
J. Immunol.
180, 3305-3312
|Abstract »|Full Text »|PDF »
Niemann-Pick C1-Like 1 Is Required for an LXR Agonist to Raise Plasma HDL Cholesterol in Mice.
W. Tang, Y. Ma, L. Jia, Y. A. Ioannou, J. P. Davies, and L. Yu (2008)
Arterioscler Thromb Vasc Biol
28, 448-454
|Abstract »|Full Text »|PDF »
Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse.
J. J. Repa, H. Li, T. C. Frank-Cannon, M. A. Valasek, S. D. Turley, M. G. Tansey, and J. M. Dietschy (2007)
J. Neurosci.
27, 14470-14480
|Abstract »|Full Text »|PDF »
Fenofibrate reduces intestinal cholesterol absorption via PPAR{alpha}-dependent modulation of NPC1L1 expression in mouse.
M. A. Valasek, S. L. Clarke, and J. J. Repa (2007)
J. Lipid Res.
48, 2725-2735
|Abstract »|Full Text »|PDF »
Novel Role for the Liver X Nuclear Receptor in the Suppression of Lung Inflammatory Responses.
M. A. Birrell, M. C. Catley, E. Hardaker, S. Wong, T. M. Willson, K. McCluskie, T. Leonard, S. N. Farrow, J. L. Collins, S. Haj-Yahia, et al. (2007)
J. Biol. Chem.
282, 31882-31890
|Abstract »|Full Text »|PDF »
The Nuclear Receptor Cofactor, Receptor-Interacting Protein 140, Is Required for the Regulation of Hepatic Lipid and Glucose Metabolism by Liver X Receptor.
B. Herzog, M. Hallberg, A. Seth, A. Woods, R. White, and M. G. Parker (2007)
Mol. Endocrinol.
21, 2687-2697
|Abstract »|Full Text »|PDF »
Liver X Receptor-{alpha} Gene Expression Is Positively Regulated by Thyroid Hormone.
K. Hashimoto, S. Matsumoto, M. Yamada, T. Satoh, and M. Mori (2007)
Endocrinology
148, 4667-4675
|Abstract »|Full Text »|PDF »
Differential expression, distribution, and function of PPAR-{gamma} in the proximal and distal colon.
W. Su, C. R. Bush, B. M. Necela, S. R. Calcagno, N. R. Murray, A. P. Fields, and E. A. Thompson (2007)
Physiol Genomics
30, 342-353
|Abstract »|Full Text »|PDF »
Estrogen Deprivation and Inhibition of Breast Cancer Growth in Vivo through Activation of the Orphan Nuclear Receptor Liver X Receptor.
H. Gong, P. Guo, Y. Zhai, J. Zhou, H. Uppal, M. J. Jarzynka, W.-C. Song, S.-Y. Cheng, and W. Xie (2007)
Mol. Endocrinol.
21, 1781-1790
|Abstract »|Full Text »|PDF »
Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux.
A. Pirillo, P. Uboldi, G. Pappalardo, H. Kuhn, and A. L. Catapano (2007)
Cardiovasc Res
75, 566-574
|Abstract »|Full Text »|PDF »
Sterol Regulatory Element-binding Protein-2- and Liver X Receptor-driven Dual Promoter Regulation of Hepatic ABC Transporter A1 Gene Expression: MECHANISM UNDERLYING THE UNIQUE RESPONSE TO CELLULAR CHOLESTEROL STATUS.
N. Tamehiro, Y. Shigemoto-Mogami, T. Kakeya, K.-i. Okuhira, K. Suzuki, R. Sato, T. Nagao, and T. Nishimaki-Mogami (2007)
J. Biol. Chem.
282, 21090-21099
|Abstract »|Full Text »|PDF »
A Key Role for Orphan Nuclear Receptor Liver Receptor Homologue-1 in Activation of Fatty Acid Synthase Promoter by Liver X Receptor.
K. E. Matsukuma, L. Wang, M. K. Bennett, and T. F. Osborne (2007)
J. Biol. Chem.
282, 20164-20171
|Abstract »|Full Text »|PDF »
SREBP-1-independent regulation of lipogenic gene expression in adipocytes.
M. Sekiya, N. Yahagi, T. Matsuzaka, Y. Takeuchi, Y. Nakagawa, H. Takahashi, H. Okazaki, Y. Iizuka, K. Ohashi, T. Gotoda, et al. (2007)
J. Lipid Res.
48, 1581-1591
|Abstract »|Full Text »|PDF »
Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors.
N. Zelcer, N. Khanlou, R. Clare, Q. Jiang, E. G. Reed-Geaghan, G. E. Landreth, H. V. Vinters, and P. Tontonoz (2007)
PNAS
104, 10601-10606
|Abstract »|Full Text »|PDF »
Selective Activation of Liver X Receptors by Acanthoic Acid-Related Diterpenes.
P. G. Traves, S. Hortelano, M. Zeini, T.-H. Chao, T. Lam, S. T. Neuteboom, E. A. Theodorakis, M. A. Palladino, A. Castrillo, and L. Bosca (2007)
Mol. Pharmacol.
71, 1545-1553
|Abstract »|Full Text »|PDF »
Mammalian Target of Rapamycin Activation Impairs Hepatocytic Differentiation and Targets Genes Moderating Lipid Homeostasis and Hepatocellular Growth.
R. Parent, D. Kolippakkam, G. Booth, and L. Beretta (2007)
Cancer Res.
67, 4337-4345
|Abstract »|Full Text »|PDF »
Multiple Roles of the Nuclear Receptors for Oxysterols Liver X Receptor to Maintain Male Fertility.
D. H. Volle, K. Mouzat, R. Duggavathi, B. Siddeek, P. Dechelotte, B. Sion, G. Veyssiere, M. Benahmed, and J.-M. A. Lobaccaro (2007)
Mol. Endocrinol.
21, 1014-1027
|Abstract »|Full Text »|PDF »
Liver X Receptor Alpha Associates With Human Life Span.
S. P. Mooijaart, M. Kuningas, R. G. J. Westendorp, J. J. Houwing-Duistermaat, P. E. Slagboom, P. C. N. Rensen, and D. van Heemst (2007)
J Gerontol A Biol Sci Med Sci
62, 343-349
|Abstract »|Full Text »|PDF »
A Mutant Thyroid Hormone Receptor {alpha} Antagonizes Peroxisome Proliferator-Activated Receptor {alpha} Signaling in Vivo and Impairs Fatty Acid Oxidation.
Y.-Y. Liu, R. S. Heymann, F. Moatamed, J. J. Schultz, D. Sobel, and G. A. Brent (2007)
Endocrinology
148, 1206-1217
|Abstract »|Full Text »|PDF »
Oxysterol Nuclear Receptor LXRbeta Regulates Cholesterol Homeostasis and Contractile Function in Mouse Uterus.
K. Mouzat, M. Prod'Homme, D. H. Volle, B. Sion, P. Dechelotte, K. Gauthier, J.-M. Vanacker, and J.-M. A. Lobaccaro (2007)
J. Biol. Chem.
282, 4693-4701
|Abstract »|Full Text »|PDF »
PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine.
Liver X Receptors Regulate Adrenal Steroidogenesis and Hypothalamic-Pituitary-Adrenal Feedback.
M. Nilsson, T. M. Stulnig, C.-Y. Lin, A. L. Yeo, P. Nowotny, E. T. Liu, and K. R. Steffensen (2007)
Mol. Endocrinol.
21, 126-137
|Abstract »|Full Text »|PDF »
International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor.
D. D. Moore, S. Kato, W. Xie, D. J. Mangelsdorf, D. R. Schmidt, R. Xiao, and S. A. Kliewer (2006)
Pharmacol. Rev.
58, 742-759
|Abstract »|Full Text »|PDF »
International Union of Pharmacology. LXIII. Retinoid X Receptors.
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer (2006)
Pharmacol. Rev.
58, 760-772
|Abstract »|Full Text »|PDF »
Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
K. E. Matsukuma, M. K. Bennett, J. Huang, L. Wang, G. Gil, and T. F. Osborne (2006)
J. Lipid Res.
47, 2754-2761
|Abstract »|Full Text »|PDF »
Ceramide structural features required to stimulate ABCA1-mediated cholesterol efflux to apolipoprotein A-I.
Correction of Apolipoprotein A-I-mediated Lipid Efflux and High Density Lipoprotein Particle Formation in Human Niemann-Pick Type C Disease Fibroblasts.
E. Boadu, H. Y. Choi, D. W. K. Lee, E. I. Waddington, T. Chan, B. Asztalos, J. E. Vance, A. Chan, G. Castro, and G. A. Francis (2006)
J. Biol. Chem.
281, 37081-37090
|Abstract »|Full Text »|PDF »
The RXR Agonist Bexarotene Improves Cholesterol Homeostasis and Inhibits Atherosclerosis Progression in a Mouse Model of Mixed Dyslipidemia.
F. Lalloyer, C. Fievet, S. Lestavel, G. Torpier, J. van der Veen, V. Touche, S. Bultel, S. Yous, F. Kuipers, R. Paumelle, et al. (2006)
Arterioscler Thromb Vasc Biol
26, 2731-2737
|Abstract »|Full Text »|PDF »
Oxidative stress influences cholesterol efflux in THP-1 macrophages: Role of ATP-binding cassette A1 and nuclear factors.
V. Marcil, E. Delvin, A. T. Sane, A. Tremblay, and E. Levy (2006)
Cardiovasc Res
72, 473-482
|Abstract »|Full Text »|PDF »
Human immunodeficiency virus infection and macrophage cholesterol metabolism..